Influence of CETP on High-Density Lipoprotein Subclasses in Patients with Coronary Heart Disease

Clinical Laboratory
|November 12, 2020
PubMed

Insights

Cholesteryl ester transfer protein (CETP) influences high-density lipoprotein (HDL) subclasses in coronary heart disease (CHD) patients. Increased CETP levels are linked to smaller HDL particles and reduced large HDL, impacting cholesterol transport.

Area of Science:

  • Cardiovascular Science
  • Lipid Metabolism
  • Biochemistry

Background:

  • Inhibition of cholesteryl ester transfer protein (CETP) reduces atherosclerotic cardiovascular disease risk by increasing high-density lipoprotein cholesterol (HDL-C).
  • The specific impact of CETP on HDL subclass distribution in coronary heart disease (CHD) patients remains unclear.

Purpose of the Study:

  • To investigate the correlation between plasma CETP levels and the distribution of HDL subclasses in patients with CHD.
  • To understand how CETP influences various HDL subclasses and their relationship with lipid profiles in CHD.

Main Methods:

  • Selected 121 healthy controls and 139 CHD patients for the study.
  • Measured plasma CETP and HDL subclass levels using ELISA and 2D gel electrophoresis.
  • Analyzed correlations between CETP, HDL subclasses, and biochemical parameters (TG, TC, LDL-C, HDL-C, apoA1, apoB100) using correlation and regression analyses.

Main Results:

  • Elevated CETP correlated with increased triglycerides (TG), total cholesterol (TC), and apoB100/A1 ratio, and decreased HDL-C and apoA1.
  • Higher CETP levels were associated with decreased large HDL subclasses (HDL2a, HDL2b) and increased small preβ1-HDL.
  • The influence of CETP on preβ1-HDL and HDL2a was more pronounced in CHD patients with higher TC and TG levels.

Conclusions:

  • HDL subclass distribution is associated with CETP levels in CHD patients, particularly those with elevated TC and TG.
  • CETP promotes the formation of small preβ1-HDL and reduces large HDL subclasses, suggesting a role in limiting reverse cholesterol transport and HDL maturation.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
492
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
451
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.1K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
203
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
694